2024 France Therapeutic Drug Monitoring (TDM) Market for 28 Assays: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
This new 247-page report from LeadingMarketResearch.com provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report is available by section, and can be customized to specific information needs and budget.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.This report is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.Contains 247 pages and 17 tables
Introduction
Market and Technology Overview
A. Major Therapeutic Drug Monitoring Tests
1. OVERVIEW
2. AMIKACIN
3. APIXABAN
4. ARGATROBAN
5. BETRIXABAN
6. CARBAMAZEPINE
7. CYCLOSPORIN
8. DABIGATRAN
9. DIGOXIN
10. EDOXABAN
11. EVEROLIMUS
12. FLUINDIONE
13. GENTAMICIN
14. LEVETIRACETAM
15. LITHIUM
16. METHOTREXATE
17. NAPA/PROCAINAMIDE
18. PHENOBARBITAL
19. PHENYTOIN
20. QUINIDINE
21. RIVAROXABAN
22. SIROLIMUS
23. TACROLIMUS
24. THEOPHYLLINE
25. TOBRAMYCIN
26. TOPIRIMATE
27. VALPROIC ACID
28. VANCOMYCIN
29. WARFARIN
B. Instrumentation Review: Operating characteristics and
features of high-, medium-, and low-volume/POC analyzers
manufactured by Abaxis, Abbott, Alere/Inverness,
Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus,
Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba,
Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox,
Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers
Table of Contents (Continued)
C. Major In Vitro Diagnostic Technologies
And Their Potential Applications
1. MONOCLONAL AND POLYCLONAL ANTIBODIES
2. IMMUNOASSAYS
a. Technological Principle
d. Chemiluminescence
c. Enzyme Immunoassays (EIA)
° Overview
° ELISA
° EMIT
° Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. TANDEM MASS SPEC
4. IT AND AUTOMATION
5. DRY CHEMISTRY
6. BIOSENSORS
D. Market Size, Growth and Major Supplier Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION
Market and Technology Overview
A. Major Therapeutic Drug Monitoring Tests
1. OVERVIEW
2. AMIKACIN
3. APIXABAN
4. ARGATROBAN
5. BETRIXABAN
6. CARBAMAZEPINE
7. CYCLOSPORIN
8. DABIGATRAN
9. DIGOXIN
10. EDOXABAN
11. EVEROLIMUS
12. FLUINDIONE
13. GENTAMICIN
14. LEVETIRACETAM
15. LITHIUM
16. METHOTREXATE
17. NAPA/PROCAINAMIDE
18. PHENOBARBITAL
19. PHENYTOIN
20. QUINIDINE
21. RIVAROXABAN
22. SIROLIMUS
23. TACROLIMUS
24. THEOPHYLLINE
25. TOBRAMYCIN
26. TOPIRIMATE
27. VALPROIC ACID
28. VANCOMYCIN
29. WARFARIN
B. Instrumentation Review: Operating characteristics and
features of high-, medium-, and low-volume/POC analyzers
manufactured by Abaxis, Abbott, Alere/Inverness,
Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus,
Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba,
Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox,
Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers
Table of Contents (Continued)
C. Major In Vitro Diagnostic Technologies
And Their Potential Applications
1. MONOCLONAL AND POLYCLONAL ANTIBODIES
2. IMMUNOASSAYS
a. Technological Principle
d. Chemiluminescence
c. Enzyme Immunoassays (EIA)
° Overview
° ELISA
° EMIT
° Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. TANDEM MASS SPEC
4. IT AND AUTOMATION
5. DRY CHEMISTRY
6. BIOSENSORS
D. Market Size, Growth and Major Supplier Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION
